For individuals who develop an unexpected psychosis, there is something to be said for testing them for autoimmune antibodies. And something against. At the 36th Congress of the European College of Neuropsychopharmacology (ECNP) this week, the topic was worth a controversy session, where speakers presented the pros and cons of the approach.
Waaree Renewable Technologies Ltd, a subsidiary company, will open the group’s first solar module manufacturing plant outside India, in Texas, US, the CMD said
Arialys Therapeutics Inc. launched this month with $58 million in seed funding, an experimental compound it is developing for autoimmune encephalitis and autoimmune psychosis, and high aspirations for its field. “Yes, I want to treat these patients, I want these patients to have a better life. But I also want drug discovery and development folks to think differently about discovering new drugs for the CNS,” Jay Lichter told BioWorld.
The development of new energy production capacities from renewable sources is being held back at the moment by some of the prosumers, who instead of satisfying their need for self-consumption have turned into real energy producers, as well as by the speculators of some energy projects, said Sebastian Burduja, the Minister of Energy, and George Niculescu - the president of the National Energy Regulatory Authority (ANRE), yesterday, during the launch conference of the second edition of the "Code of good practices in the renewable energy sector", a work carried out by Romania Energy Wind Association (RWEA) in partnership with the Romanian Photovoltaic Industry Association (RPIA).